Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Martin Shkreli
Martin Shkreli
Martin Shkreli pleads for $3M bail reduction to pay legal fees
USA Today
Sun, 06/18/17 - 11:55 pm
Martin Shkreli
Scott Gottlieb has some ideas about blocking any more would-be Martin Shkrelis from price gouging
Endpoints
Mon, 05/29/17 - 11:29 am
Scott Gottlieb
FDA
Martin Shkreli
drug pricing
Scoop: Turing is considering a $100M cash offer for the drug that triggered a national scandal over drug pricing
Endpoints
Wed, 05/10/17 - 09:44 am
Turing Pharmaceuticals
Daraprim
Martin Shkreli
Martin Shkreli asks judge to order document hand-over, bar other evidence from use at trial
CNBC
Wed, 04/26/17 - 09:43 pm
Martin Shkreli
Martin Shkreli wins bid for separate trial from co-defendant on securities fraud charges
CNBC
Thu, 04/20/17 - 09:45 am
Martin Shkreli
securities fraud
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Bizjournals.com
Fri, 03/10/17 - 09:39 am
Retrophin
Cambridge
Martin Shkreli
Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A
Bizjournals.com
Tue, 02/21/17 - 10:26 pm
Biogen
drug pricing
Martin Shkreli
Shkreli defends drug prices, spars with protesters at heated UMass Boston event
Bizjournals.com
Fri, 02/17/17 - 09:48 am
Martin Shkreli
drug pricing
protesters
Ex-drug company CEO Shkreli to speak at Harvard
Stat
Mon, 02/13/17 - 09:58 am
Martin Shkreli
Harvard
Martin Shkreli asks federal judge for permission to speak at Harvard University event
CNBC
Thu, 02/9/17 - 09:31 pm
Martin Shkreli
Accused fraudster Martin Shkreli involved in new company that is seeking $1 million in debt offering
CNBC
Wed, 02/8/17 - 09:30 pm
Martin Shkreli
Martin Shkreli in court as securities fraud case moves closer to trial
CNBC
Thu, 01/26/17 - 06:56 pm
Martin Shkreli
securities fraud
Retrophin
Why we should listen to Martin Shkreli
Stat
Thu, 01/26/17 - 10:20 am
Martin Shkreli
drug pricing
Banned from Twitter, Martin Shkreli whips up a new online tirade in response to a mocking dig from PhRMA chief
Endpoints
Wed, 01/25/17 - 09:49 am
Martin Shkreli
social media
twitter
PhRMA
Martin Shkreli: Mallinckrodt Will Be Punished
Benzinga
Thu, 01/19/17 - 08:35 am
Martin Shkreli
Mallinckrodt
Questcor
Daraprim
Yes, Martin Shkreli can drop his bad boy persona, at least for one moment
Endpoints
Fri, 12/2/16 - 11:59 pm
Martin Shkreli
Daraprim
drug pricing
innovation
Martin Shkreli pleads the 5th
Thu, 10/27/16 - 04:05 pm
Here's How To Punch Martin Shkreli In The Face
Forbes
Wed, 09/28/16 - 10:15 am
Martin Shkreli
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Wed, 09/7/16 - 10:04 am
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis
Martin Shkreli, the obscene prankster of biotech, makes his final exit at KaloBios
Endpoints
Mon, 08/29/16 - 09:10 am
Martin Shkreli
KaloBios
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »